Skip to content
value.today

Exscientia PLC

EXAIUnlisted company
$745 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—

About Exscientia PLC

Exscientia plc is a biotechnology company with automate drug design and are the first to have an AI Designed molecule enter clinical trials. The company annual revenue is 9.6 million GBP and total assets are 77.7 million GBP as on 2020. The headquarters is in UK.

Exscientia PLC timeline

2 events, 2012–2021
  1. 2012
  2. 🏁
    · approximate
    Founded
  3. 2021
  4. 🔔
    · approximate
    Initial public offering on Nasdaq

Events of Exscientia PLC from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

More about Exscientia PLC

Acquisitions and changes
No longer listed: ticker EXAI is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).

Market cap history

$0 M$652 M$1.3 B$2.0 B$2.6 B20232024

World rank over time

▼ down 4,607 places since 2022
2022-01-07: #5579#5,57920222022-12-25: #11931#11,93120222023-07-30: #8948#8,94820232024-01-05: #10186#10,1862024

Rank in UK: #245 (Jan 2022) · #427 (Dec 2022) · #325 (Jul 2023) · #354 (Jan 2024)

Markets and events: Exscientia PLC#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2024-11-15
3.0 M
3.22 days to cover

Trading halts

  • 2024-11-20 00:50 UTC, code D, resumed 05:00 UTC

Fails to deliver

  • : 3,781 shares at $4.84
  • : 13,220 shares at $4.84
  • : 18,576 shares at $4.84
  • : 8,031 shares at $4.69
  • : 259,000 shares at $5.31
CompanyMarket capP/ENet marginRev. growth
Exscientia PLC🇬🇧$745 M———
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
UnitedHealth Group Incorporated🇺🇸$367.7 B23.1×3.5%+11.8%
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Thermo Fisher Scientific Inc.🇺🇸$253.8 B35.9×14.9%+3.9%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

How current the figures are

Market cap:
Jan 5, 2024 (last known)
Profile updated:
Nov 14, 2026

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Exscientia PLC? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Exscientia PLC's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Exscientia PLC? Suggest a correction